The global Cell-free fetal DNA testing market is estimated to be valued at USD 1,687.8 million in 2025 and is projected to reach USD 3,051.5 million by 2035, registering a compound annual growth rate ...

Aldevron’s Alchemy™ is an exclusive cell-free DNA technology which cuts research grade linear DNA manufacturing time by over 50 percent, accelerating mRNA development projects with cleaner ...

Cell-free DNA analyses were accurate in detecting fetal antigen status as early as 10 weeks’ gestation in women with alloimmunized pregnancies, according to results of a large, diverse U.S ...

Conventional Cell-Based versus Cell-Free Gene Synthesis. Conventional cell-based gene synthesis requires a more complicated, time- and resource-intensive workflow to assemble, sequence, amplify, and ...

More information: Hua Bao et al, Early detection of multiple cancer types using multidimensional cell-free DNA fragmentomics, Nature Medicine (2025). DOI: 10.1038/s41591-025-03735-2 ...

Cell-free DNA testing uses a small amount of a person's blood and tests it for a large number of cancers. A positive test could indicate that the person has a certain type of cancer in theory ...

For the new cell-free DNA testing, a small amount of a person's blood is tested for a large number of cancers. A positive test could indicate that the person has a certain type of cancer in theory ...